Abstract
Gene delivery into the spinal cord provides a potential approach to the treatment of spinal cord traumatic injury, amyotrophic lateral sclerosis, and spinal muscular atrophy. These disorders progress over long periods of time, necessitating a stable expression of functional genes at therapeutic levels for months or years. We investigated in this study the feasibility of achieving prolonged transgene expression in the rat spinal cord through repeated intrathecal administration of plasmid DNA complexed with 25 kDa polyethylenimine (PEI) into the lumbar subarachnoid space. With a single injection, DNA/PEI complexes could provide transgene expression in the spinal cord 40-fold higher than naked plasmid DNA. The transgene expression at the initial level persisted for about 5 days, with a low-level expression being detectable for at least 8 weeks. When repeated dosing was tested, a 70% attenuation of gene expression was observed following reinjection at a 2-week interval. This attenuation was associated with apoptotic cell death and detected even using complexes containing a noncoding DNA that did not mediate any gene expression. When each component of the complexes, PEI polymer or naked DNA alone, were tested in the first dosing, no reduction was found. Using polyethylene glycol (PEG)-grafted PEI for DNA complexes, no attenuation of gene expression was detected after repeated intrathecal injections, even in those rats receiving three doses, administered 2 weeks apart. Lumbar puncture is a routine and relatively nontraumatic clinical procedure. Repeated administration of DNA complexed with PEG-grafted PEI through this less invasive route may prolong the time span of transgene expression when needed, providing a viable strategy for the gene therapy of spinal cord disorders.
Similar content being viewed by others
References
Costantini LC, Bakowska JC, Breakefield XO, Isacson O . Gene therapy in the CNS. Gene Therapy 2000; 7: 93–109.
O'Leary MT, Charlton HM . A model for long-term transgene expression in spinal cord regeneration studies. Gene Therapy 1999; 6: 1351–1359.
Yamamura J et al. Long-term gene expression in the anterior horn motor neurons after intramuscular inoculation of a live herpes simplex virus vector. Gene Therapy 2000; 7: 934–941.
Boussif O et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 1995; 92: 7297–7302.
Abdallah B et al. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum Gene Ther 1996; 7: 1947–1954.
Goula D et al. Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Therapy 1998; 5: 712–717.
Li S et al. Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors. Am J Physiol 1999; 276 (Part 1): L796–L804.
Meyer O, Schughart K, Pavirani A, Kolbe HV . Multiple systemic expression of human interferon-beta in mice can be achieved upon repeated administration of optimized pcTG90-lipoplex. Gene Therapy 2000; 7: 1606–1611.
Jenkins RG et al. An integrin-targeted non-viral vector for pulmonary gene therapy. Gene Therapy 2000; 7: 393–400.
Imaoka T, Date I, Ohmoto T, Nagatsu T . Significant behavioral recovery in Parkinson's disease model by direct intracerebral gene transfer using continuous injection of a plasmid DNA–liposome complex. Hum Gene Ther 1998; 9: 1093–1102.
Jackson CA et al. Repetitive intrathecal injections of poliovirus replicons result in gene expression in neurons of the central nervous system without pathogenesis. Hum Gene Therapy 2001; 12: 1827–1841.
Ram Z et al. Intrathecal gene therapy for malignant leptomeningeal neoplasia. Cancer Res 1994; 54: 2141–2145.
Meuli-Simmen C et al. Gene expression along the cerebral-spinal axis after regional gene delivery. Hum Gene Ther 1999; 10: 2689–2700.
Martino G, Furlan R, Comi G, Adorini L . The ependymal route to the CNS: an emerging gene therapy approach for MS. Trends Immunol 2001; 22: 483–490.
Harris JM, Zalipsky S (eds). Poly(ethyleneglycol): Chemistry and Biological Applications. ACS Book: Washington, DC, 1997.
Godbey WT, Wu KK, Mikos AG . Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. Biomaterials 2001; 22: 471–480.
Ogris M, Brunner S, Schuller S, Kircheis R, Wagner E . PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Therapy 1999; 6: 595–605.
Nguyen HK et al. Evaluation of polyether–polyethlenimine graft copolymers as gene transfer agents. Gene Therapy 2000; 7: 126–138.
Kichler A et al. Intranasal gene delivery with a polyethylenimine–PEG conjugate. J Controlled Release 2002; 81: 379–388.
Petersen H et al. Polyethylenimine–graft–poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery dystem. Bioconjug Chem 2002; 13: 845–854.
Mannes AJ, Caudle RM, O'Connell BC, Iadarola MJ . Adenoviral gene transfer to spinal cord neurons: intrathecal vs. intraparenchymal administration. Brain Res 1998; 793: 1–6.
Tan Y, Li S, Pitt BR, Huang L . The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo. Hum Gene Ther 1999; 10: 2153–2161.
Fabry Z, Raine CS, Hart MN . Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol Today 1994; 15: 218–224.
Stevenson PG, Hawke S, Sloan DJ, Bangham CR . The immunogenicity of intracerebral virus infection depends on anatomical site. J Virol 1997; 71: 145–151.
Detrait ER et al. Reporter gene transfer induces apoptosis in primary cortical neurons. Mol Ther 2002; 5: 723–730.
Wang S et al. Transgene expression in the brain stem effected by intramuscular injection of polyethylenimine/DNA complexes. Mol Ther 2001; 3: 658–664.
Klinman DM, Yamshchikov G, Ishigatsubo Y . Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol 1997; 158: 3635–3639.
Choia YH et al. Polyethylene glycol-grafted poly–L-lysine as polymeric gene carrier. J Control Release 1998; 54: 39–48.
Lee M et al. Repression of GAD autoantigen expression in pancreas-β-cells by delivery of antisense plasmid/PEG–g-PLL complex. Mol Ther 2001; 4: 339–346.
Sagara K, Kim SW . A new synthesis of galactose–poly–L-lysine pancreas-β-cells for gene delivery to hepatocytes. J Control Release 2002; 79: 271–281.
Ahn CH, Char SY, Bae YH, Kim SW . Biodegradable poly(ethylenimine) for plasmid DNA delivery. J Control Release 2002; 80: 273–282.
Francis GE et al. PEGylation of cytokines and other therapeutic proteins and peptides: the importance of biological optimisation of coupling techniques. Int J Hematol 1998; 68: 1–18.
Harris JM, Martin NE, Modi M . Pegylation: a novel process for modifying pharmacokinetics. Clin Pharmacokinet 2001; 40: 539–551.
Hinds KD, Kim SW . Effects of PEG conjugation on insulin properties. Adv Drug Deliv Rev 2002; 54: 505–530.
Chillon M, Lee JH, Fasbender A, Welsh MJ . Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitro. Gene Therapy 1998; 5: 995–1002.
O'Riordan CR et al. PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. Hum Gene Ther 1999; 10: 1349–1358.
Croyle MA, Chirmule N, Zhang Y, Wilson JM . ‘Stealth’ adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung. J Virol 2001; 75: 4792–4801.
Acknowledgements
This work was funded by the Agency for Science, Technology and Research (A*STAR).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shi, L., Tang, G., Gao, S. et al. Repeated intrathecal administration of plasmid DNA complexed with polyethylene glycol-grafted polyethylenimine led to prolonged transgene expression in the spinal cord. Gene Ther 10, 1179–1188 (2003). https://doi.org/10.1038/sj.gt.3301970
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301970
- Springer Nature Limited
Keywords
This article is cited by
-
Bio-nano interactions: binding proteins, polysaccharides, lipids and nucleic acids onto magnetic nanoparticles
Biomaterials Research (2021)
-
AKAP150 and its Palmitoylation Contributed to Pain Hypersensitivity Via Facilitating Synaptic Incorporation of GluA1-Containing AMPA Receptor in Spinal Dorsal Horn
Molecular Neurobiology (2021)
-
Effective gene expression in the rat dorsal root ganglia with a non-viral vector delivered via spinal nerve injection
Scientific Reports (2016)
-
Serum resistant and enhanced transfection of plasmid DNA by PEG-stabilized polyplex nanoparticles of L-histidine substituted polyethyleneimine
Macromolecular Research (2015)
-
Improved axonal regeneration of transected spinal cord mediated by multichannel collagen conduits functionalized with neurotrophin-3 gene
Gene Therapy (2013)